CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
GALVANI aims to improve treatment for drug-resistant epilepsy by using non-invasive brain stimulation techniques. The project focuses on understanding how weak electric fields can modulate brain activity, develop personalized treatment protocols, and test these methods in patients to enhance therapeutic outcomes.
Epilepsy is a neurological disorder affecting 65 million people worldwide.
Pharmacological treatments or surgery are ineffective in one third of the cases – 19 million people.
Recent findings indicate that non-invasive brain transcranial current stimulation (tCS) is safe and of therapeutic promise in epilepsy.
However, it is not yet indicated as a standard treatment due to major scientific limitations: unknown mechanisms of action, insufficient account for patient-specific factors, poor understa…
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, RENNES
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Marseille
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, BARCELONA
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
